The Association between Lifestyle Choices and Schizophrenia Symptoms

Due to poor eating habits, insufficient physical activity, and nicotine use, schizophrenia patients are at increased risk of lifestyle diseases. Factors contributing to unhealthy behaviors include lower socioeconomic status and level of education as well as social isolation. Schizophrenia manifestations such as amotivation, apathy, and cognitive deficits can further hinder development of proper health habits. The aim of this study was to assess the possible association between lifestyle-related choices and schizophrenia symptoms severity. This observational study enrolled 106 patients with schizophrenia (42 Males/64 Females), 18-69 years (mean: 41.89 +/- 9.7 years). Mean duration of schizophrenia was 14.61 +/- 9.7 years. Multiple significant correlations were found between patients' lifestyle and their biochemical laboratory parameters (lipid profile and fasting glucose). Most importantly, a significant link emerged between presented habits and schizophrenia symptom severity. There were also significant gender differences in the intake of sweets and sweet beverages. Quite unexpectedly, a behavioral shift towards more healthy lifestyle choices was observed after completion of questionnaires on lifestyle and health habits. There are clear benefits to systematic provision of educational interventions concerning physical activity and proper eating habits to schizophrenia patients. These simple preventive measures could significantly improve both mental and physical health outcomes in schizophrenia patient populations.

Automated summary

Schizophrenia patients are at increased risk of lifestyle diseases due to poor eating habits, lack of physical activity, and nicotine use. This study found significant correlations between patients' lifestyle choices, biochemical parameters, and the severity of schizophrenia symptoms. Educational interventions on physical activity and healthy eating habits could lead to improved mental and physical health outcomes for schizophrenia patients.